Alzheimer’s disease clinical trials and studies need a wide range of participants in order to find potential treatments and cures. An intervention may work differentlyin one gender, race, age, or health status group than in another. Without enough trial participants from diverse backgrounds, questions about a treatment may remain unanswered.
Share this information on social media:
|
Una mirada al pasado Edinson Martínez martes 23 de abril de 2024
Hace 44 minutos
No hay comentarios:
Publicar un comentario